| Insider | Role | Shares | Value | Buys | Sells |
|---|---|---|---|---|---|
| Date | Ticker | Insider | Role | Type | Shares | Price | Value | Chg% | SEC |
|---|---|---|---|---|---|---|---|---|---|
| Insider | Role | Shares | Value | Buys | Sells |
|---|---|---|---|---|---|
| Date | Ticker | Insider | Role | Type | Shares | Price | Value | Chg% | SEC |
|---|---|---|---|---|---|---|---|---|---|
Cerus Corporation (CERS) has 11 insiders with recent SEC Form 4 filings, including 5 buys and 1 sell. CERS is classified in the Health Care Equipment & Supplies industry within the Health Care sector.
| Role | Insider | Shares | Value | 30d |
|---|---|---|---|---|
| CEO | 5.45M | $14.16M | - | |
| COO | 1.66M | $4.31M | -16,667 | |
| CFO | 1.17M | $3.04M | - | |
| Other | 1.06M | $2.75M | - | |
| Other | 879.1K | $2.29M | - |
Buys and sells only
| Date | Insider | Role | Type | Shares | Price | Value | Chg% | SEC |
|---|---|---|---|---|---|---|---|---|
| Aug 18, 2015 | Corash Laurence M73 | Chief Scientific Officer | Buy | 84,600 | $4.77 | $403,464.79 | +2.3% | |
| Aug 13, 2015 | Corash Laurence M73 | Chief Scientific Officer | Buy | 50,000 | $4.98 | $249,045.00 | +4.5% | |
| Aug 12, 2015 | Corash Laurence M73 | Chief Scientific Officer | Buy | 25,000 | $4.82 | $120,550.00 | +2.3% | |
| Aug 14, 2014 | Benjamin Richard J71 | Chief Medical Officer | Sale+OE | 35,416 | $7.20 | $255,016.45 | -100% |